학술논문
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
Document Type
Article
Author
Bauer, J.; Maringer, Y.; Bilich, T.; Nelde, A.; Dubbelaar, M.; Scheid, J.; Wacker, M.; Schroeder, S.; Rieth, J.; Denk, M.; Richter, M.; Walz, J.S.; Rammensee, H.-G.; Bucher, P.; Heitmann, J.S.; Bitzer, M.; Feucht, J.; Salih, H.R.; Hailfinger, S.; Köhler, N.; Zwick, M.; Holzer, U.; Ebinger, M.; Brecht, I.B.; Dicks, S.; Boerries, M.; Klein, R.; Bonzheim, I.; Luibrand, J.
Source
In: Nature Communications . (Nature Communications, December 2022, 13(1))
Subject
Language
English
ISSN
20411723